Synonyms: ONO 5334 | ONO5334
Compound class:
Synthetic organic
Comment: ONO-5334 is a cysteine protease inhibitor with activity against cathepsin K. It was an oral drug lead that was considered as a bone resorption inhibitor for the treatment of postmenopausal osteoporosis. ONO-5334 has some antiviral activity against SARS-CoV-2, and antagonises viral replication in human iPSC-derived pneumocyte-like cells [2].
|
|
No information available. |
Summary of Clinical Use ![]() |
ONO-5334 was progressed to Phase 2 clinical evaluation and has completed a trial in osteoporosis and osteopenia. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT00532337 | Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis | Phase 2 Interventional | Ono Pharmaceutical Co. Ltd | Cathepsin K inhibition with ONO-5334 increased bone mineral density at 24 months and no clinically relevant safety concerns were identified. Biochemical markers of bone resorption that were modulated by ONO-5334 normalised rapidly following withdrawl of treatment. | 1 |